CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
about
Purinergic signalling and cancerA Metabolic Immune Checkpoint: Adenosine in Tumor MicroenvironmentConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesThe mTOR pathway and integrating immune regulationEctonucleotidases in tumor cells and tumor-associated immune cells: an overviewInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapyAdenosine receptors as drug targets--what are the challenges?Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancerImmune cell regulation by autocrine purinergic signalling.Purinergic signaling during inflammation.Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment.CD39 and CD161 modulate Th17 responses in Crohn's disease.Big opportunities for small molecules in immuno-oncology.Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death.Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in miceCharacterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel diseaseImpact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer.Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α.Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal TissuesCD73 promotes tumor growth and metastasisNADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantationDisordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null miceActivated mouse CD4(+)Foxp3(-) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity.Overexpression of CD39 and high tumoral CD39⁺/CD8⁺ ratio are associated with adverse prognosis in resectable gastric cancerγδ T Cells Protect the Liver and Lungs of Mice from Autoimmunity Induced by Scurfy LymphocytesTargeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.CD39 and CD73 in immunity and inflammation.5'-AMP impacts lymphocyte recirculation through activation of A2B receptors.Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancerUtility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancerIL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.Making sense of regulatory T cell suppressive function.Pathological roles of purinergic signaling in the liver
P2860
Q24618782-D0EC055A-F830-48D8-9491-FBE45A8883A5Q26749571-32E348FD-AB3D-4E11-84D5-DDB81F711970Q26781215-156A5F34-6D55-4919-9773-9A946D4F675CQ26830354-C8C1921F-273B-48CB-81F9-DEDD289D058AQ27002950-A511857D-66F0-4869-90D8-A1D61A25CC0FQ27008625-4F4C46B8-A177-4116-9FC9-669E8F31D810Q29346491-8361FFA5-9522-423A-B593-A7F5086B7E9DQ33608626-F2127DFB-05A7-4F50-AD60-E431F4D5BD00Q34025783-430A322B-9875-4E80-BC20-A9373F037F3DQ34034751-76AAD11B-63DE-4A0D-B1BA-65AF85E45550Q34100538-D619FF86-3824-4C89-9791-28EC4BC32C23Q34218735-970AC12C-54B0-431D-A13C-A2FDF50E808FQ34487689-EA2A1322-922B-4585-84BC-C59115BC9749Q34542781-F67F2334-278E-471A-B1CA-56793784CA27Q34633667-7E9B8CDA-598C-4469-9F77-F06F5FCAE964Q34658181-5481320F-9B3A-4A70-B097-AAD424FF5256Q34703746-C4566584-54B5-4B86-918A-DA4864EB4255Q35015717-54EB3557-5096-4D58-8A7F-AB36DA8C4C76Q35088318-0DFC42BB-208D-44BB-A2FE-F92B949C4B40Q35136797-124EA47E-47E9-47C6-B132-72D6C58DE839Q35765467-28678887-37F7-4CDA-AE15-1D42CED49490Q35973670-54CCB8EE-6E1C-4508-8FE1-6BE20D42E226Q36038399-FD0C2B7B-E94A-4511-820A-D65E06BDEEC1Q36341390-B447D457-05FC-4F86-8680-D9A6C6F68A2DQ36350059-77413176-6B40-42B9-B5AF-A7868B39C4BBQ36420128-7DD0E9D2-D869-4A02-96B2-C05CC63C686DQ36449146-6FBFBBEE-15E1-42CE-AE22-BA4962CF9B7BQ36464610-621B6DF0-11CB-4709-84CA-E6C10A3BDA90Q36553627-A6BCA817-CED1-4F3C-B123-94D3FC8A4378Q36620552-6C6F7726-FD3E-4CEF-851B-720C63997286Q36906658-3CC33CE7-55D9-4767-A5C2-5D2D90A4E823Q36935733-82492F6C-0B16-4576-81E0-FCFAF303EFDEQ37109246-D48EC075-0C4A-47B2-9FBC-790D949F9E47Q37222138-D85A607B-1D3B-4FED-89ED-E55778B67E11Q37251564-C594CF9C-D05C-4EC4-89E2-CC81B255874FQ37659617-9F1481F5-C459-427C-A377-2F17DDDF5675Q37680218-CC78C1F4-E98D-488F-B931-056EBB4259BBQ37876541-BD33940B-5CF9-4BC2-AA86-856B14407CEDQ37877042-A0F37CE3-0D66-4FCA-AF34-D80073BCCDE3Q38019642-79F809B4-FA40-44BE-9ED2-BE205160F859
P2860
CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@ast
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@en
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@nl
type
label
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@ast
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@en
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@nl
prefLabel
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@ast
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@en
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@nl
P2093
P2860
P1433
P1476
CD39/ENTPD1 expression by CD4+ ...... etastatic tumor growth in mice
@en
P2093
Keiichi Enjyoji
Simon C Robson
Takashi Murakami
Xiaofeng Sun
P2860
P304
P356
10.1053/J.GASTRO.2010.05.007
P407
P577
2010-06-25T00:00:00Z